Cardiovascular
Hypertensive heart disease
Abnormal enlargement of the heart resulting from long-standing hypertension.
Starter kit · coming soon
Start building on hypertensive heart disease
Open datasets
Imaging, genomics, clinical and text data you can use today
Benchmarks
Existing tasks and leaderboards to measure against
Open questions
Unsolved problems where a model could help
See a finished example: the malaria starter kit →
Where the field stands
01
Early understanding
No strong gene target or drug candidate yet
02
Target found
At least one gene target with strong evidence
03
Drug candidates
Preclinical or phase 1 drug candidates
04
In trials
Drug candidates in phase 2 or later
05
Has approved drugs
At least one approved drug; not necessarily a cure
Derived from Open Targets drug and target data, not self-reported.
Healthy years lost (DALYs), 2023
28.4M
95% range 22.7M to 35.2M
Deaths, 2023
1.5M
People living with it, 2023
13.4M
GBD cause: Hypertensive heart disease (exact match)
Research attention
What there is to build on
Open Targets Platform ↗Gene targets with strong evidence
0
of 311 associated genes
Top associated genes
FTOFGF5UMODAPOL1KCNK3
Drugs and clinical candidates
3
Approved drugs
0
Identifiers
- Open Targets
- MONDO_0001302
- ICD-10
- I11
Read these numbers with care
- No standard subject heading, so the paper count uses a keyword search and runs low.
- GBD counts this as its own cause, but most research is labeled hypertension; trial and paper counts likely understate attention.
Trial and paper counts are rough measures of attention, not of progress. This page is for research planning, not medical advice.